Walder Wyss with SIS Medical on investment by Claret
Walder Wyss advised Swiss medtech company SIS Medical in connection with an investment by Claret Capital Partners — a growth debt fund manager with a focus in technology, life sciences and climate tech companies across Europe.
The company
Headquartered in Frauenfeld, SIS Medical develops, manufactures, and distributes cardiovascular products, tailored for the treatment of challenging coronary lesions affected by calcification.
The Walder Wyss team
Managing associate Anaëlle Genoud (banking & finance, pictured) led the Walder Wyss team on the matter, working alongside partner Alexander Gutmans (corporate/M&A), partner Iliana Djagova (corporate / M&A) and associate Lorenzo Petrone (corporate/M&A), as well as partner and notary André Kuhn for the notary services.